The use of hydrogenated - ergot alkaloids for the treatment of puerperal galactorrhoea

摘要

Hydrogenated ergot alkaloids, specifically dihydroergocristine and/or dihydroergocryptine and/or their pharmaceutically acceptable salts, are used to manufacture medicaments for use in treating puerperal galactorrhea. The compositions, which are for internal use (e.g. as tablets or injections) may also contain dihydroergocornine.